Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.